BioPharm International
CONTINUE TO SITE >

OR WAIT 15 SECS

BioPharm International-06-01-2020

BioPharm International

Following Guidelines During a Crisis

June 02, 2020

Ask the Expert

33

6

Products must be manufactured in accordance with appropriate regulatory requirements, even during a pandemic, says Susan J. Schniepp, executive vice-president of post-approval pharma and distinguished fellow, Regulatory Compliance Associates.

2019 Investments Centered around Cell and Gene Therapies

June 01, 2020

Operations

33

6

Previous investments set a foundation for later efficiency improvements.

What’s Next in Air Transportation

June 01, 2020

Operations

33

6

The future will bring changes for temperature-controlled container rental companies.

Are We All In This Together?

June 01, 2020

From the Editor

33

6

Achieving herd immunity will require testing, data, a vaccine, and public support.

Generic Drugs in Spotlight as Pandemic Creates Shortages

June 01, 2020

Regulatory Beat

33

6

FDA and the US Congress support innovation and access to cheaper medicines.

BioPharm International, June 2020 Issue (PDF)

June 01, 2020

Issue PDF

33

6

Click the title above to open the BioPharm International June 2020 issue in an interactive PDF format.